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It is well established that desoxycorticosterone acetate (DCA) is capable of 
producing a  rise in the blood pressure of a  wide variety of species  including 
man (1,  2).  In the earlier animal experiments, large doses of the steroid or 
intensifying measures appeared necessary to elicit the reaction (3).  Recently, 
however, we have been able to demonstrate that the pressor response can be 
elicited in the intact rat by small amounts of DCA without any additional sensi- 
tization and that the use of saline as drinking water intensifies the process but 
does not alter it qualitatively (4).  Like others, we have concluded that the in- 
tensifying effect of saline resides in the sodium ion, although we have suggested 
that other ions may likewise be capable of increasing the effects (5). 
Following on this, it appeared that the next phase of the problem was to 
elucidate the mechanism of action of DCA.  We had noted that  the rise in 
blood pressure in the rat appeared to be independent of alterations in renal 
function as determined by the clearance of inulin and sodium para-aminohip- 
purate.  Indeed, as in essential hypertension in man, the rise in blood pressure 
occurred before any change in renal function was demonstrable, and consider- 
ably preceded the onset of renal ischemia.  Further, the intensification of renal 
functional derangement was not paralleled by any increase in the degree of 
pressor response.  The suggestion that the pressor effects of DCA were inde- 
pendent of the kidney, and that the renal changes occurred secondarily, perhaps 
as a  result of the hypertensive process itself, seemed reasonable, particularly 
since Goldman and Schroeder had recently demonstrated an immediate pressor 
response in man to administered DCA (6).  In all our experiments, both pub- 
lished and unpublished however, we had noted that even where renal function 
as measured was undisturbed by DCA, kidney weight was increased.  In other 
words, normal renal function was maintained only by hypertrophy.  It thus 
became necessary to establish firmly whether kidney changes were or were not 
correlated with the pressor response. 
Experiment  1 
The experiments here reported were planned with the basic idea that the re- 
lation between blood pressure rise and kidney involvement could most easily 
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be demonstrated by studying these two factors not only as they progressed fol- 
lowing DCA administration, but also as they regressed following withdrawal 
of DCA. 
One hundred and ten albino rats of the Sherman strain, averaging approximately 90 gin. 
in weight were divided into two groups.  Forty-one animals served as untreated controls while 
the remaining 69 received DCA with 1 per cent saline as drinking water ad libitum.  DCA 
was administered as one-third of a 75 nag. pellet (Schering cortate) subcutaneously implanted 
on the 1st day of the experiment and every 2 weeks thereafter.  During the 4th week of the 
experiment renal function (7) and blood pressure (8) were determined in a group of 9 of the con- 
trol and 18 of the DCA-saline-treated animals.  Immediately following these procedures the 
control group and half of the  treated  group were sacrificed, their kidneys fixed, and then 
weighed.  Pellets were removed from the remaining half of  the  DCA-sallne-treated  group 
which were then returned to tap water. 
During the 6th week of the experiment renal function and blood pressure were again deter- 
mined in a group of 8 control and 20 of the DCA-safine-treated animals, as well as in the group 
whose DCA-saline treatment had stopped 2 weeks earlier. Again, all animals were sacrificed 
except for half of the DCA-saline-treated group in which treatment was stopped at this time. 
During the 8th week, the usual procedures were carried out in a control group, in a DCA- 
saline-treated  group, and in the group whose treatment had been stopped in the previous 
period.  Insufficient DCA-saline-treated  animals remained to permit the experiment to be 
carried out beyond this period.  Consequently, a subsidiary experiment was set up to deter- 
mine the effects of stopping treatment in the 8th week.  The base line data for control and 
DCA-sallne-treated groups in the 8th week were again determined.  Treatment was stopped 
in half of the treated  group and their renal function and blood pressure determined again 1 
week later. 
Briefly, the clearance technique was as follows: PAH solution (12.5 mg./cc, in 2 per cent 
sodium sulfate) is injected into the lumbar region in accordance with a dose-body weight scale 
calculated to yield the desired plasma level of 5 to 7 rag. per cent at 50 minutes.  Immediately 
following this injection, 3 cc. of warm 2 per cent inulin solution is injected intraperitoneally. 
The completion of this second injection marks the start of the urine collection period, and the 
rat is immediately placed into a metabolism funnel. 
Fifty minutes after injection, the rat is picked up over the funnel and the bladder drained 
by suprapubic pressure, although micturition is usually free and spontaneous.  Immediately 
following  urine collection, 0.75 ec. of blood is obtained by heart puncture.  Plasma and urine 
are then analyzed for inulin and PAH. 
Blood pressure determinations are made with the tail plethysmograph using ether as anes- 
thetic.  While this method may fail to record a raised pressure in the occasional animal which 
is actually hypertensive, experience in many hundreds of animals indicates that it gives reliable 
and reproducible results.  The actual pressure recorded is somewhat below the systolic level. 
The results obtained in the two separate parts of the experiment (up to the 
8th week, and then beyond this period) are presented in Table I.  The number 
of animals indicated in each case refers to those sacrificed in that particular 
period.  For simplicity, and in order to clarify the significant findings, the data 
have been rearranged graphically in Fig. 1.  In this figure, the findings are pre- 
sented as percentage deviation of the test group values from those obtained in 
a group of intact controls studied on the same day.  Changes which are statisti- 
cally significant (p  <  0.02) are denoted. TABLE  I 
Blood Pressure, Renal Function, and Kidney Weigl~ Determined in Croups of Sherman  Rats 
at Various Stages of Treatment with DCA and Saline, and Subsequent to tl~ Cessation of 
Treatment 
No. of animals 
Blood pressure.. 
CIN, ¢¢./100 cm.t, 
tth wk. C1,~, cc./lO0 ¢ra.s.. 
TmPAH~ mg./lO0 on.t. . . 
FF asper cent... 
CpAn/Tmpsm. • 
Kidney weight, mg./lO0 cm3. 
No. of animals .... 
Blood pressure 
CIN  ,  co./J00  On.  s. 
~th w  k. CPAH, c¢./lO00n.l .... 
']~',PAH, mg./JO0 ¢m3 ........ 
FF as per cent ...... 
CPAtl/TmpAH 
Kidney weight, mg./lO0 oa.2. 
No. of animals ..................................... 
Blood pressure  .................................... 
CIN  , CO./ZOO  ¢~.~  ............................... 
8th wk. CPAH, cc./lO0 ¢m.  2 .............................. 
TmpAH, mg./lO0 era3 ............................. 
FF as per cent .................................... 
CpAH/TmpAH  ................................... 
Kidney weight, mg./lO0 cm.t ...................... 
Control 
9 
106 
:4-12 
0.34 
4-0.08 
2.48 
•  4-0.33 
0.125 
~0.014 
13.7 
19.8 
397  554 
-4-42  -4-44 
8  10 
111  134 
•  4-16  -4-16 
0.31 
d:O.  07 
2.47 
-4-0.27 
0.127 
-I-0.010 
12.5 
19.4 
439 
-4-49 
8 
107 
-4-13 
0.33 
DCA-sallne 
DCA-sslIne  trestment stop- 
ped in previous 
, period 
9 
131 
4-16 
0.34 
4-0.08 
2.70 
4-0.45 
0.121 
4-0.021\ 
12.9  \ 
22.2 
2.81  2.73 
-4.-0.76  -4-0.37 
0.134  0.129 
-4-0.033  :L-0.011 
11.4  12.4 
20.9~  21.2 
580  \  507 
--I-93  .4-30 
I0  k::j::lO 
151  97 
17 
Not graphed  I  ~  0.39 
I  ~::t:0.08  -4-0.08 
2.59 
-4-0.27 
0.120 
-v0.017 
12.7 
21.7 
459  602 
.-I-45 
2.87 
•  4-0.39 
0,131 
-4-0.015 
13.7 
21.9 
501 
:/:30 
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TABLE I--Condud~ 
No. of animals ........ 
Blood pressure 
CIN. CC./IO0  ~.1. 
8th wk. CpXlS, cc.IIO0  ¢m.I .... 
TmPAH, MJL/IO0 ~.Z .... 
FF as per cent .......... 
Ce,~/Tme~a~ 
Kidney weight, m&./lO0 ¢m.*. . 
No. O[ an~ma|s ....... 
Blood pressure .... 
CIN,  cc./lO0 ¢m.s ....... 
Pth wk. C'~A~, ec.]lO0 cm.I.. 
'I~pAH, mg./lO0 cm.t. . 
FF, as per cent. 
CpaH/l~p~a ........ 
Kidney weight, mg./lO0 ¢m,  s ........... 
Control 
8 
106 
d:12 
0.29 
:L-0.0$ 
2.6, 
::hO.7, 
0.,40 
:~o.o22 
ILl 
18.7 
388 
.4:32 
8 
108 
a..-l$ 
0.27 
~'-0.0,1 
2.$1 
a..-O.  17 
0.1~ 
:~-0.013 
,0.7 
16.7 
388 
-,'-32 
DCA-saline 
13 
146 
0.46 
:L-O.,4 
2.67 
::]:0.31 
0.125 
:L-0.014. 
17.2  / 
21.2 
$62 
-4-30 
DCA-sallne 
treatment stop- 
ped in previous 
period 
-"  8 
117 
~  0.29 
~-~-0.05 
2.60 
~'-.0.19 
0.144 
~-.0.01! 
tl.2 
15.0 
507 
The inulin clearance, CIN, measures the glomerular filtration rate (GFR).  The clearance of PAH, CPAH, 
measures the renal plasma flow (RPF) at the plasma levels of PAH used.  TmpAB represents the minute tubular 
excretion d  PAH and hence measures the functioning tubular excretory  mass.  The ratio CIN JCpAH represents 
the fraction of plasma filtered at the glomemins and is termed filtration fraction (FF).  The ratio CpAH/TmpAH 
expresses the plasma flow for each unit of functioning tubular excretory tissue. 
The black arrows in this table connect the functional data of groups as detemdned before and after ces~tlon 
of treatment.  At the same time the table is arranged so  that hori~ntsl resd/ng ~Iows comparison between 
groups us~sed at the same time. 
Blood Pressure.--Blood pressure was significantly elevated as early as 25 days 
after the start of the experiment in the DCA-saline-treated animals and re- 
mained so throughout the 51 days of the treatment.  Upon cessation of treat- S. M. FRIEDMAN  AND  C. L. ~FRIEDMAN  635 
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i  °  DCR-Sal!  Jt 
~0 
,~.ot  !  I i 
-10  ~~ 
71  da~s 
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BCR-Sati~ ~lda~s 
+  b dabs ~itboot tre.alment 
FIo. I.  Blood pressure, renal function, and kidney weight determined in groups of Sherman 
rats at various stages of treatment with DCA and saline, and subsequent to the cessation of 
treatment.  The actual data on which this figure is based are presented in Table I. 636  DESOXYCORTICOSTERONE  ACETATE  HYPERTENSION 
ment either at 25, 37, or 51 days, blood pressure fell promptly to normal levels. 
Indeed, 6 days after cessation of DCA treatment which had been carried on for 
51 days, a significant elevation of pressure was no longer demonstrable.  Since 
blood pressure determinations were not carried out at times other than those 
specified in the table, the return of the elevated pressure to normotensive levels 
may have occurred even more rapidly than is here indicated. 
Renal Funcgion.--Renal function appeared  undisturbed  after 25  days and 
after 37 days of treatment with DCA-saline.  This is in accord with our pre- 
vious finding that Sherman animals do not develop renal functional changes 
as readily as do Wistar (9).  Fifty-one days of treatment resulted in a  signi- 
ficant increase in the glomerular filtration rate, and consequently, in the filtra- 
tion fraction.  Since in the two earlier periods renal function as here deter- 
mined was unaffected by the DCA-saline treatment, it is not surprising that 
no real change was observed 12 days after cessation of treatment in either case. 
The marked deviation in filtration rate observed after 51  days of treatment 
disappeared 6 days after treatment was stopped. 
The data concerning renal function fall in the same direction as others which 
we have reported and would, alone, suggest that the elevation in blood pressure 
is  independent  of renal  functional  derangement.  Further,  since  change  in 
renal function may only be observed relatively late in the course of treatment, 
the idea that it results from the elevated pressure might well be entertained. 
This suggestion is, however, contradicted by the observations concerning renal 
weight. 
Kidney Weight.--Bearing in  mind  the obvious fact that  changes  in  renal 
mass  can probably not  occur as  rapidly as alterations in blood pressure,  a 
remarkable parallel between these functions was observed.  Elevation of the 
blood pressure even at  the earliest date studied was accompanied by an in- 
crease in kidney weight, while restoration of  the blood pressure  was accom- 
panied by a  return towards normal of kidney weight.  Since renal function 
was maintained only at the normal level despite this increase in size, it seems 
reasonable to assume that this process is a compensatory hypertrophy. 
It is of some interest in relation to the theory of renal function tests  that 
this renal involvement becomes apparent at once when renal function is related 
to actual renal mass. 
The apparent correlation between renal mass and blood pressure was sub- 
jected  to  statistical  analysis.  In  Fig.  2,  renal  mass  in  the  DCA-saline-- 
treated animals is plotted as a  frequency distribution against blood pressure, 
the data being taken from part one of the experiment.  The regression line for 
the data in which b, the coefficient of regression is 0.124,  is statistically signif- 
icant.  Since this graph represents all treated animals, whether or not pellets 
were removed, the significant regression assumes even greater meaning.  The s. ~. FgI~DM.AZ~  AND  c.  L. FgI~D~N  637 
conclusion that the kidneys are in some way involved in DCA hypertension 
from the beginning of the process appears unavoidable. 
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FIG. 2. Renal mass in DCA-saline-treated animals plotted as a frequency distribution 
against blood pressure. 
Experiment 2 
Since the kidneys are thus apparently immediately involved following DCA 
administration,  two  major  possibilities  concerning  the  mechanism  suggest 
themselves--(a) the kidneys liberate a pressor substance upon stimulation by 
DCA or (b)  the kidneys are actively concerned in the excretion and possible 
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It seemed to us that the first step in distinguishing between these possibil- 
ities would be to examine the effects of DCA on blood pressure in the absence 
of the kidneys. The basic principle followed was to administer DCA until the 
blood pressure had attained a predetermined level, and then to nephrectomize 
the animals.  A fall in pressure following nephrectomy would offer strong sup- 
port to the idea that the pressor effect of DCA had been mediated by the kid- 
ney, perhaps through stimulation of a renal pressor mechanism.  On the other 
hand,  a  rise in the blood pressure  following nephrectomy would indicate that 
the pressor action of DCA was a  more direct phenomenon. 
Four separate experiments were carried out.  In two of these, the blood pres- 
sure was elevated  to a  significant but low degree before nephrectomy so that 
either a  fall or a  rise might be easily discerned.  Two were performed at an 
earlier  stage in DCA treatment  when  the blood pressure  was not yet signifi- 
cantly  elevated.  Since  all  four  experiments  yielded  the  same  fundamental 
result only one experiment of each group is here reported. 
Experimen~ 2a.--Twenty-eight male albino rats of an inbred Wistar  strain and approxi- 
mately 150 gin. in weight were maintained for 29 days.  Eight animals served as untreated 
controls while the remaining 20 received a DCA pellet (one-third of a 75 rag. cortate pellet) as 
a subcutaneous implant on the 1st and 14th days of the experiment.  On the 20th day, the 
left kidney was removed from each of 12 of the DCA-treated animals and on the 27th day of 
the experiment the remaining kidneys were removed.  Blood pressure was determined at 1 or 
2 day intervals beginning on the 18th day.  The findings for this experiment are presented in 
Fig. 3.  Seven  of the 12 nephrectomized animals survived for the blood pressure determination 
24 hours after complete nephrectomy, 2 for the 48 hour period. 
Blood pressure was significantly elevated in the DCA-treated groups at the 
time of the first blood pressure determination on the 18th day.  A fall in blood 
pressure  occurred immediately following removal of one kidney but this  was 
only temporary.  In contrast,  24 hours  after  removal of the  second kidney, 
a  significant  elevation  above both  untreated  and  DCA-treated  controls  was 
observed in the blood pressure of the nephrectomized animals.  This result  is 
the more remarkable since it occurred despite the undoubted operative shock, 
a factor not present in the control groups, and was observed not only as a group 
average but also in 6 of the 7 survivors, while the pressure of the seventh ani- 
mal did not fall.  The further elevation observed at 48 hours cannot be con- 
sidered since it is based on only two survivors. 
Expcrlmcn~ 2b.--Thirty male albino rats of an inbred Wistar strain, approximately  150 gm. 
in weight, were maintained for 14 days.  Fifteen of these animals received 2 pellets (one-third 
of a cortate pellet) on the 1st day of the experiment and a third pellet on the 6th day.  On the 
12th day, 9 control and 9 DCA-treated animals were subjected to a one stage bilateral nephrec- 
tomy.  Blood pressure was determined daily beginning on the llth day.  The results are pre- 
sented in Fig. 4.  All animals survived in good shape for 24 hours, but only 4 of the DCA- 
treated and 1 of the untreated nephrectomized animals were available for the 48 hour deter- 
ruination. S. M. FRIEDMAN  AND  C. L. FRIEDMAN  639 
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FIo. 3. The blood pressure in DCA-treated rats before and after removal of the kidneys. 
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FzG. 4.  The blood pressure in DCA-treated rats before and after removal of the kidneys. 640  DESOXYCORTICOSTERONE  ACETATE  HYPERTENSION 
Prior to nephrectomy no elevation in blood pressure was observed in any 
group although 2 days later the DCA-treated animals were beginning to show 
a  rise.  Twenty-four hours after removal of both kidneys blood pressure was 
elevated  in  both DCA-treated  and  untreated  nephrectomized animals.  In 
the case of the untreated group, this finding was significant but resulted from 
an elevation of pressure in only 3 of the 9 animals.  On the other hand, all 9 
DCA-treated nephrectomized animals participated in the observed elevation 
in this group, an elevation statistically significant not only in reference to the 
untreated control level but also in reference to the moderate elevation in the 
two other groups.  The 48 hour findings are based on too few data to permit 
discussion. 
DISCUSSION 
Earlier workers had observed that when DCA was administered to suitably 
sensitized animals, hypertension and renal damage occurred.  They assumed 
that the kidneys were primarily involved in DCA hypertension, although such 
a conclusion was not necessarily warranted by the data.  Reinvestigating the 
problem from a functional approach we drew attention to the absence of renal 
functional change at a time when hypertension following DCA administration 
was well established, and pointed to the similarity of this observation to the 
findings  in  essential  hypertension.  Further  exploration aimed at  both the 
progression of DCA hypertension and its regression upon cessation of treatment 
showed, however, that the kidneys are involved from the start in the process. 
Attention is drawn particularly to those data which show clearly how compensa- 
tory hypertrophy may completely mask the presence of interference with renal 
function. 
After removal of both kidneys, an aggravation of the hypertension was ob- 
served in DCA-treated animals.  It is thus unlikely that the kidney enlarge- 
ment reflects a  stimulated production of renal pressor material, but it seems 
reasonable to suggest that the kidney is actively concerned with the excretion 
and possible inactivation of the steroid. 
It is also possible to explain these findings according to Grollman's view that 
the kidney normally liberates an antihypertensive factor (10).  In the present 
state of information, however, it  is  not possible  to  distinguish between  the 
idea of a renal antihypertensive factor on the one hand and the renal destruc- 
tion of a pressor agent on the other. 
SUMMARY 
Desoxycorficosterone acetate  in pellet  form was administered for 51 days to 
albino  rats  of  the Sherman strain  which also  received  I  per cent  saline  as  drink- 
ing water.  Treatment was stopped in representative  groups at 25, 37, and 
51 days so that the regression  of  blood pressure  and renal  changes could be ob- s.  M.  FRIEDMAN AND C.  L.  FRIEDMAN  641 
served.  It was noted that both the elevation in blood pressure during treat- 
ment and its reversal when treatment was stopped were closely correlated with 
corresponding changes in renal mass.  In the time for which the process was 
studied it did not become irreversible. 
Removal of both kidneys from DCA-treated animals aggravated the hyper- 
tension, suggesting that the kidneys are actively concerned with the excretion 
and possible inactivation of the steroid. 
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